Clinical Trials Logo

Psychomotor Agitation clinical trials

View clinical trials related to Psychomotor Agitation.

Filter by:

NCT ID: NCT02022488 Completed - Emergence Agitation Clinical Trials

Sevoflurane Induced Emergence Agitation

Start date: February 2012
Phase: Phase 4
Study type: Interventional

Investigators evaluated the effect of intranasal ketamine or alfentanil addition to oral midazolam for prevention of emergence agitation.Seventy-eight, 1-8 year-old children, undergoing urological surgery with sevoflurane anesthesia was included in the study. All the children received oral midazolam 0.5 mg/kg 40 minutes before anesthesia induction then enrolled to one of the study groups, randomly. Ketamine group (Group MK; n=26) patients were given 2mg/kg intranasal ketamine whereas, alfentanil group (Group MA; n=25) were given 10microgram/kg intranasal alfentanil 8-10 min before the induction of anesthesia. Saline group (Group MS; n=27) received intranasal isotonic saline.Parental separation, mask acceptance were evaluated with a 4- point scale. Emergence agitation was evaluated with Pediatric Anesthesia Emergence Delirium score.

NCT ID: NCT02017392 Not yet recruiting - Clinical trials for Postoperative Agitation of Patients

A RCT of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for GA

Start date: December 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether the compound lidocaine cream is effective in preventing postoperative agitation in patients with endotracheal intubation for general anesthesia.

NCT ID: NCT02011191 Completed - Clinical trials for End Stage Renal Disease

Biotin Deficiency and Restless Legs Syndrome

Start date: December 2006
Phase: N/A
Study type: Interventional

Restless Leg Syndrome (RLS) is a common neuropathic disorder in patients with end stage renal disease (ESRD). Study Design: Because micronutrient depletion has been associated with RLS in ESRD and because the vitamin biotin is dialyzable, the investigators examined the relationship between biotin status and RLS in ESRD. Objectives: To assess the prevalence of biotin deficiency in those with and without RLS (Study 1) and to determine the effect of biotin supplementation on RLS symptoms (Study 2) in patients receiving chronic dialysis due to ESRD.

NCT ID: NCT01981941 Completed - Clinical trials for Restless Legs Syndrome (RLS)

Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment

Start date: November 5, 2013
Phase: Phase 4
Study type: Interventional

To evaluate the safety, efficacy and pharmacokinetics of gabapentin enacarbil in moderate to severe primary RLS patients with moderate renal impairment and to confirm dosage and administration in such population.

NCT ID: NCT01976871 Active, not recruiting - Clinical trials for Restless Legs Syndrome

Switching From Oral Dopamine Agonists to Rotigotine

SWITCH
Start date: August 2014
Phase: Phase 4
Study type: Interventional

The primary objective is to demonstrate safety and tolerability of switching patients with Restless Legs Syndrome (RLS) from an oral dopamine agonist to rotigotine. As a secondary objective, the investigators will evaluate control of RLS symptoms on rotigotine compared to the prior oral regimen.

NCT ID: NCT01976754 Completed - Sepsis Clinical Trials

Safety Study of Dexmedetomidine in Septic Patients

Start date: September 2013
Phase: N/A
Study type: Interventional

Septic patients in Intensive Care Unit always need mechanical ventilation and conscious-sedation. But the recommended dose 0.2-0.7μg/kg/h could not run well because of wide range. The purpose of this study is to find the effective dose of dexmedetomidine adult septic patients of mechanical ventilation .

NCT ID: NCT01967303 Completed - Stroke Clinical Trials

Restless Legs Syndrome in Stroke Patients

Start date: January 2008
Phase: N/A
Study type: Observational

Our study aimed to examine a possible association between Restless legs syndrome and cerebrovascular disease, by examining patients during hospitalization for acute stroke or transient ischemic attack, in a matched case-control design.

NCT ID: NCT01942343 Completed - Akathisia Clinical Trials

Akathisia in Post Operative Outpatients Surgery

Start date: October 2013
Phase: Phase 3
Study type: Interventional

The main objective of this study is to evaluate the incidence of akathisia with Droperidol, the prophylactic treatment of post operative nausea and vomiting, used at two different doses, versus control group (Ondansetron), in outpatient surgery.The primary endpoint is to compare the number of observed akathisia (Barnes score > 1) in the Droperidol arms (0,625 mg and 1,25 mg) versus Ondansetron 4 hours after recovery from anesthesia.The assumption is that there is a greater risk of akathisia among patients taking Droperidol in prevention of NPVO, that among patients taking Ondansetron.

NCT ID: NCT01931878 Active, not recruiting - Clinical trials for Restless Leg Syndrome

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Start date: September 2012
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to compare the safety and effectiveness of local injections of botulinum toxin A (Xeomin®) to an inactive test substance (placebo) in a medical condition called Restless Leg Syndrome. This study has a double blind cross over design. Cross over means that you will have two sets of injections. The first set of injections can be either Xeomin or placebo. The order of injection will be reversed at the three month point following the first injection. Double blind means neither the investigators nor you know which one of the two (Xeomin or placebo) you received.

NCT ID: NCT01922258 Completed - Alzheimer's Disease Clinical Trials

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Start date: September 2013
Phase: Phase 3
Study type: Interventional

To compare the efficacy of flexible dosing of brexpiprazole with placebo in subjects with agitation associated with dementia of the Alzheimer's type